Status:
COMPLETED
Validation of the Moroccan Arabic Version of the Low Anterior Resection Syndrome (LARS) and Wexner Score of Continence Among Rectal Cancer Patients
Lead Sponsor:
Moroccan Society of Surgery
Collaborating Sponsors:
Institut National d'Oncologie Sidi Mohammed Ben Abdellah
Conditions:
Rectal Cancer Patients
Eligibility:
All Genders
18+ years
Brief Summary
In the past decade, colorectal cancer management improved considerably with total mesorectal excision as well as the multidisciplinary management relying on neoadjuvant radiochemotherapy. This forward...
Detailed Description
The translation of the LARS and WEXNER score to the moroccan dialect ( arabic ) has been done in another study using translation and back translation in concordance with the international guidelines. ...
Eligibility Criteria
Inclusion
- Patients aged older than 18 years.
- Neoplasm of the rectum.
- Rectal cancer patients undergoing curative sphincter-preserving surgery with (partial or total) mesorectal excision.
- Surgery performed between January 2012 to March 2019, with reversal of the defunctioning stoma before March 2019;
- Bowel continuity restoration for at least 6 months.
- Consent to participate in the study.
Exclusion
- Palliative surgery.
- The presence of a definitive iliac or perineal stoma.
- Diseases of bowel dysfunction (Crohn's disease)
- Cognitive and/or language issues.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2019
Estimated Enrollment :
143 Patients enrolled
Trial Details
Trial ID
NCT04128657
Start Date
January 1 2019
End Date
October 31 2019
Last Update
February 20 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institut of Oncology, Surgical oncology department
Rabat, Please Enter the State Or Province, Morocco, 10100
2
Private surgical oncology center
Salé, Morocco